Publication date: Jan 01, 2019 Relapsing-remitting multiple sclerosis (RRMS) has a major impact on affected patients; therefore, improved understanding of RRMS is important, particularly in the context of real-world evidence. ... Read more

Publication date: Jan 22, 2019 To assess real-world durability of reduction in relapse rates among patients with multiple sclerosis (MS) receiving fingolimod therapy over a longer-term period of follow-up. Patients ... Read more

Publication date: Feb 15, 2019 Considerable gaps exist in knowledge regarding the prevalence of neurologic diseases, such as multiple sclerosis (MS), in the United States. Therefore, the MS Prevalence Working ... Read more

Publication date: Feb 19, 2019 Expression of ectonucleotidase CD39 contributes to the suppressive activity of Foxp3 regulatory T cells (Tregs) by hydrolyzing immunogenic ATP into AMP. The molecular mechanism that ... Read more

Publication date: May 09, 2018 Depression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to ... Read more

Publication date: Feb 15, 2019 Angiopoietin-like proteins (ANGPTLs) are a group of proteins with functions in lipid metabolism, angiogenesis, and inflammation. Here, we investigated their involvement in multiple sclerosis (MS) ... Read more

Publication date: Feb 18, 2019 Kelsey, R. Prodromal symptoms might vary between multiple sclerosis subtypes. 17374. 2019 Nat Rev Neurol.

Read more

Publication date: Feb 18, 2019 Aβ peptide abnormal production is associated with the development and maintenance of neuroinflammation and oxidative stress in brains from Alzheimer disease (AD) patients. Suppression of ... Read more

Publication date: Feb 18, 2019 To describe the resources and methods used to identify and validate multiple sclerosis (MS) and match non-MS patients in each of the two databases, and ... Read more

Publication date: Feb 18, 2019 We recently reported successful treatment of a child with febrile infection-related epilepsy syndrome (FIRES), a subtype of new-onset refractory status epilepticus (NORSE), with the recombinant ... Read more